Importantly, our data suggest that the ability of tumor cell SPN to limit T cell killing is dependent on its modification with core 2 O-glycans, which is consistent with previous findings on the anti-adhesive functions of both SPN and MUC131,32,39,40. The gene discussed is SPN; the disease is neoplasm.